JP2011500790A - 毛状疣贅の治療および予防のための金属収斂剤の使用 - Google Patents
毛状疣贅の治療および予防のための金属収斂剤の使用 Download PDFInfo
- Publication number
- JP2011500790A JP2011500790A JP2010530613A JP2010530613A JP2011500790A JP 2011500790 A JP2011500790 A JP 2011500790A JP 2010530613 A JP2010530613 A JP 2010530613A JP 2010530613 A JP2010530613 A JP 2010530613A JP 2011500790 A JP2011500790 A JP 2011500790A
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- aluminum
- metal
- astringent
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 72
- 239000002184 metal Substances 0.000 title claims abstract description 72
- 238000011282 treatment Methods 0.000 title claims description 56
- 239000003212 astringent agent Substances 0.000 title abstract description 19
- 230000002265 prevention Effects 0.000 title description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 109
- 239000006260 foam Substances 0.000 claims abstract description 66
- 241000894007 species Species 0.000 claims abstract description 66
- 239000004094 surface-active agent Substances 0.000 claims abstract description 56
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 54
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 53
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 47
- 229920000642 polymer Polymers 0.000 claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 42
- 239000012141 concentrate Substances 0.000 claims abstract description 34
- 210000000003 hoof Anatomy 0.000 claims abstract description 30
- 239000002562 thickening agent Substances 0.000 claims abstract description 25
- 241001465754 Metazoa Species 0.000 claims abstract description 24
- 229910052742 iron Inorganic materials 0.000 claims abstract description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 19
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 41
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 claims description 28
- 229940009827 aluminum acetate Drugs 0.000 claims description 28
- -1 skin conditioner Substances 0.000 claims description 13
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 12
- 239000000178 monomer Substances 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical group Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- 239000003945 anionic surfactant Substances 0.000 claims description 6
- 239000003093 cationic surfactant Substances 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- XTHPWXDJESJLNJ-UHFFFAOYSA-M chlorosulfate Chemical compound [O-]S(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-M 0.000 claims description 5
- 241000208680 Hamamelis mollis Species 0.000 claims description 4
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 4
- 229910000360 iron(III) sulfate Inorganic materials 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000018553 tannin Nutrition 0.000 claims description 4
- 239000001648 tannin Substances 0.000 claims description 4
- 229920001864 tannin Polymers 0.000 claims description 4
- 229940111630 tea tree oil Drugs 0.000 claims description 4
- 239000010677 tea tree oil Substances 0.000 claims description 4
- 229940118846 witch hazel Drugs 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 3
- 229940045631 aluminum subacetate Drugs 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- WPCPXPTZTOMGRF-UHFFFAOYSA-K di(butanoyloxy)alumanyl butanoate Chemical compound [Al+3].CCCC([O-])=O.CCCC([O-])=O.CCCC([O-])=O WPCPXPTZTOMGRF-UHFFFAOYSA-K 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- GDPKWKCLDUOTMP-UHFFFAOYSA-B iron(3+);dihydroxide;pentasulfate Chemical compound [OH-].[OH-].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GDPKWKCLDUOTMP-UHFFFAOYSA-B 0.000 claims description 3
- BPLYVSYSBPLDOA-GYOJGHLZSA-N n-[(2r,3r)-1,3-dihydroxyoctadecan-2-yl]tetracosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H](CO)[C@H](O)CCCCCCCCCCCCCCC BPLYVSYSBPLDOA-GYOJGHLZSA-N 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 2
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 2
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- HQQUTGFAWJNQIP-UHFFFAOYSA-K aluminum;diacetate;hydroxide Chemical compound CC(=O)O[Al](O)OC(C)=O HQQUTGFAWJNQIP-UHFFFAOYSA-K 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000004927 clay Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 11
- 230000003472 neutralizing effect Effects 0.000 abstract description 4
- 241000283690 Bos taurus Species 0.000 description 53
- 230000003902 lesion Effects 0.000 description 53
- 239000000047 product Substances 0.000 description 42
- 229910000365 copper sulfate Inorganic materials 0.000 description 23
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 23
- 238000011156 evaluation Methods 0.000 description 18
- 208000000260 Warts Diseases 0.000 description 14
- 201000010153 skin papilloma Diseases 0.000 description 14
- 239000007788 liquid Substances 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 238000009826 distribution Methods 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 235000013365 dairy product Nutrition 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000004599 antimicrobial Substances 0.000 description 6
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 6
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 6
- ZBJWWKFMHOAPNS-UHFFFAOYSA-N loretin Chemical compound C1=CN=C2C(O)=C(I)C=C(S(O)(=O)=O)C2=C1 ZBJWWKFMHOAPNS-UHFFFAOYSA-N 0.000 description 6
- 229950010248 loretin Drugs 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 208000006413 Digital Dermatitis Diseases 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000003973 alkyl amines Chemical class 0.000 description 3
- HAMGNFFXQJOFRZ-UHFFFAOYSA-L aluminum;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4] HAMGNFFXQJOFRZ-UHFFFAOYSA-L 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 3
- 239000000701 coagulant Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- WCOATMADISNSBV-UHFFFAOYSA-K diacetyloxyalumanyl acetate Chemical group [Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WCOATMADISNSBV-UHFFFAOYSA-K 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- JEJSGFPNNFSSNI-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecan-1-amine oxide Chemical compound CCCCCCCCCCCCCC[N+]([O-])(CCO)CCO JEJSGFPNNFSSNI-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 241000283153 Cetacea Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 229940063656 aluminum chloride Drugs 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RHPIJWYTYJJCFU-UHFFFAOYSA-L diacetyloxyaluminum;hydrate Chemical compound O.CC(=O)O[Al]OC(C)=O RHPIJWYTYJJCFU-UHFFFAOYSA-L 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940080691 domeboro Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 2
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 2
- YHGPYBQVSJBGHH-UHFFFAOYSA-H iron(3+);trisulfate;pentahydrate Chemical compound O.O.O.O.O.[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O YHGPYBQVSJBGHH-UHFFFAOYSA-H 0.000 description 2
- 229910000399 iron(III) phosphate Inorganic materials 0.000 description 2
- 230000003137 locomotive effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910000000 metal hydroxide Inorganic materials 0.000 description 2
- 150000004692 metal hydroxides Chemical class 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000010815 organic waste Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000004071 soot Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000005270 trialkylamine group Chemical group 0.000 description 2
- 238000002424 x-ray crystallography Methods 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 description 1
- DCNHQNGFLVPROM-QXMHVHEDSA-N (z)-n,n-dimethyloctadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN(C)C DCNHQNGFLVPROM-QXMHVHEDSA-N 0.000 description 1
- QCTZUSWOKFCWNB-QXMHVHEDSA-N (z)-n,n-dimethyloctadec-9-en-1-amine oxide Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)[O-] QCTZUSWOKFCWNB-QXMHVHEDSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical class O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- SFOKDWPZOYRZFF-UHFFFAOYSA-H 2,3-dihydroxybutanedioate;iron(3+) Chemical compound [Fe+3].[Fe+3].[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O.[O-]C(=O)C(O)C(O)C([O-])=O SFOKDWPZOYRZFF-UHFFFAOYSA-H 0.000 description 1
- CPHJEACXPATRSU-UHFFFAOYSA-N 2-[2-hydroxyethyl(tetradecyl)amino]ethanol Chemical compound CCCCCCCCCCCCCCN(CCO)CCO CPHJEACXPATRSU-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- FPFSGDXIBUDDKZ-UHFFFAOYSA-N 3-decyl-2-hydroxycyclopent-2-en-1-one Chemical compound CCCCCCCCCCC1=C(O)C(=O)CC1 FPFSGDXIBUDDKZ-UHFFFAOYSA-N 0.000 description 1
- ZUGAOYSWHHGDJY-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-aluminabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Al+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZUGAOYSWHHGDJY-UHFFFAOYSA-K 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000005955 Ferric phosphate Substances 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000034819 Mobility Limitation Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- MOWVIOXFEXDKJF-UHFFFAOYSA-L [Al+3].[Al+3].[K+].[O-]S([O-])(=O)=O Chemical compound [Al+3].[Al+3].[K+].[O-]S([O-])(=O)=O MOWVIOXFEXDKJF-UHFFFAOYSA-L 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- MJWPFSQVORELDX-UHFFFAOYSA-K aluminium formate Chemical compound [Al+3].[O-]C=O.[O-]C=O.[O-]C=O MJWPFSQVORELDX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- JGDITNMASUZKPW-UHFFFAOYSA-K aluminium trichloride hexahydrate Chemical compound O.O.O.O.O.O.Cl[Al](Cl)Cl JGDITNMASUZKPW-UHFFFAOYSA-K 0.000 description 1
- 229940009861 aluminum chloride hexahydrate Drugs 0.000 description 1
- YCLAMANSVUJYPT-UHFFFAOYSA-L aluminum chloride hydroxide hydrate Chemical compound O.[OH-].[Al+3].[Cl-] YCLAMANSVUJYPT-UHFFFAOYSA-L 0.000 description 1
- 229940053431 aluminum sesquichlorohydrate Drugs 0.000 description 1
- 229940071540 aluminum zirconium octachlorohydrex gly Drugs 0.000 description 1
- UTUUIUQHGDRVPU-UHFFFAOYSA-K aluminum;2-aminoacetate;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Al+3].NCC([O-])=O UTUUIUQHGDRVPU-UHFFFAOYSA-K 0.000 description 1
- WYANSMZYIOPJFV-UHFFFAOYSA-L aluminum;2-aminoacetic acid;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4].NCC(O)=O WYANSMZYIOPJFV-UHFFFAOYSA-L 0.000 description 1
- BBMXVTPBLPQMAE-UHFFFAOYSA-K aluminum;docosanoate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCCCCCC([O-])=O BBMXVTPBLPQMAE-UHFFFAOYSA-K 0.000 description 1
- XNLYYQDZUNCJRA-UHFFFAOYSA-N aluminum;hypobromous acid Chemical compound [Al].BrO XNLYYQDZUNCJRA-UHFFFAOYSA-N 0.000 description 1
- SJXYSRSHDPPYIU-UHFFFAOYSA-L aluminum;propane-1,2-diol;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].CC(O)CO SJXYSRSHDPPYIU-UHFFFAOYSA-L 0.000 description 1
- YXZZLAMCXFHTTE-UHFFFAOYSA-N aluminum;propane-1,2-diol;trihypochlorite;hydrate Chemical compound O.[Al+3].Cl[O-].Cl[O-].Cl[O-].CC(O)CO YXZZLAMCXFHTTE-UHFFFAOYSA-N 0.000 description 1
- DMGNPLVEZUUCBT-UHFFFAOYSA-K aluminum;propanoate Chemical compound [Al+3].CCC([O-])=O.CCC([O-])=O.CCC([O-])=O DMGNPLVEZUUCBT-UHFFFAOYSA-K 0.000 description 1
- CSJKPFQJIDMSGF-UHFFFAOYSA-K aluminum;tribenzoate Chemical compound [Al+3].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 CSJKPFQJIDMSGF-UHFFFAOYSA-K 0.000 description 1
- ZQKXOSJYJMDROL-UHFFFAOYSA-H aluminum;trisodium;diphosphate Chemical compound [Na+].[Na+].[Na+].[Al+3].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O ZQKXOSJYJMDROL-UHFFFAOYSA-H 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- BUOSLGZEBFSUDD-BGPZCGNYSA-N bis[(1s,3s,4r,5r)-4-methoxycarbonyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2,4-diphenylcyclobutane-1,3-dicarboxylate Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1C(C=2C=CC=CC=2)C(C(=O)O[C@@H]2[C@@H]([C@H]3CC[C@H](N3C)C2)C(=O)OC)C1C1=CC=CC=C1 BUOSLGZEBFSUDD-BGPZCGNYSA-N 0.000 description 1
- XWTXZJITNNRDLC-UHFFFAOYSA-K bis[(2-hydroxyacetyl)oxy]alumanyl 2-hydroxyacetate Chemical compound [Al+3].OCC([O-])=O.OCC([O-])=O.OCC([O-])=O XWTXZJITNNRDLC-UHFFFAOYSA-K 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- DSLDCLRWFVOROV-UHFFFAOYSA-L butanoate;iron(2+) Chemical compound [Fe+2].CCCC([O-])=O.CCCC([O-])=O DSLDCLRWFVOROV-UHFFFAOYSA-L 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940117583 cocamine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- XILPPDQAWPSZIL-UHFFFAOYSA-H dialuminum;dichloride;tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-] XILPPDQAWPSZIL-UHFFFAOYSA-H 0.000 description 1
- KNXDJTLIRRQLBE-UHFFFAOYSA-H dialuminum;propane-1,2-diol;chloride;pentahydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].CC(O)CO KNXDJTLIRRQLBE-UHFFFAOYSA-H 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 208000023867 digital dermatitis in cattle Diseases 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 229950010007 dimantine Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- 229940032958 ferric phosphate Drugs 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 238000009616 inductively coupled plasma Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000008258 liquid foam Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- ONHFWHCMZAJCFB-UHFFFAOYSA-N myristamine oxide Chemical compound CCCCCCCCCCCCCC[N+](C)(C)[O-] ONHFWHCMZAJCFB-UHFFFAOYSA-N 0.000 description 1
- BZDOEVMUXJTHPS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)hexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+]([O-])(CCO)CCO BZDOEVMUXJTHPS-UHFFFAOYSA-N 0.000 description 1
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 1
- NHLUVTZJQOJKCC-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCN(C)C NHLUVTZJQOJKCC-UHFFFAOYSA-N 0.000 description 1
- IBOBFGGLRNWLIL-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)[O-] IBOBFGGLRNWLIL-UHFFFAOYSA-N 0.000 description 1
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 1
- SFBHPFQSSDCYSL-UHFFFAOYSA-N n,n-dimethyltetradecan-1-amine Chemical compound CCCCCCCCCCCCCCN(C)C SFBHPFQSSDCYSL-UHFFFAOYSA-N 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940079842 sodium cumenesulfonate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- KVCGISUBCHHTDD-UHFFFAOYSA-M sodium;4-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1 KVCGISUBCHHTDD-UHFFFAOYSA-M 0.000 description 1
- QEKATQBVVAZOAY-UHFFFAOYSA-M sodium;4-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=C(S([O-])(=O)=O)C=C1 QEKATQBVVAZOAY-UHFFFAOYSA-M 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- FZUJWWOKDIGOKH-UHFFFAOYSA-N sulfuric acid hydrochloride Chemical compound Cl.OS(O)(=O)=O FZUJWWOKDIGOKH-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
表1:観察スコアリング
表6:病変の痛みのスコア分布
表8:不活性化された病変の基準に合う蓄牛
表9:例1の組成物
表10:アルミニウム化学種分析の相対的割合
表11:粘度および泡安定性−製品組成(Wt%)**
**出発原料のwt%としてではなく、活性成分基準で報告されたwt%
表12:界面活性剤組成物の泡の半減期(分)
表14:界面活性剤組成物の泡の半減期(分)
表16:界面活性剤組成物の泡の半減期(分)
表18:例3の組成物
Claims (25)
- 有蹄動物における毛状疣贅(乳頭腫性肚皮膚炎)を治療および予防するための方法、該方法は、:
(a)鉄およびアルミニウムの少なくとも1種を含む金属収斂剤を含む水溶液を調製する工程、
該金属収斂剤は、ポリマー種とモノマー種との混合物であり、そして該ポリマー種は
、該水溶液中において該金属収斂剤の約10重量%より多い;および
(b)毛状疣贅病を予防し、そして治療するために、動物の脚下部および蹄領域に、該水溶液を適用する工程、
を含んでなる。 - 金属塩の一部分がポリマー種を生成するように、該金属塩を加水分解することによって、該水溶液が調製される、請求項1の方法。
- 該水溶液が、約4.0〜6.0のpHを有する、請求項1の方法。
- 該水溶液が、増粘剤、界面活性剤、スキンコンディショナー、緩衝剤、フィルム形成ポリマー、抗菌剤、着色剤、マンサク、タンニン、およびティーツリー油の少なくとも1種をさらに含む、請求項1の方法。
- 該金属収斂剤が、塩化アルミニウム、硫酸アルミニウム、硫酸ナトリウムアルミニウム、硫酸カリウムアルミニウム、酢酸アルミニウム、アルミニウムサブアセテート、酪酸アルミニウム、塩化第二鉄、硫酸第二鉄、フェリックサブサルフェート、ポリ塩化アルミニウム、ポリ硫酸アルミニウム、ポリアルミニウムクロロ硫酸塩、ポリアルミニウムシリケートサルフェート、ポリ塩化第二鉄、ポリ硫酸第二鉄、およびポリアルミノ硫酸第二鉄の少なくとも1種を含む、請求項1の方法。
- 該ポリマー種が、該水溶液中において、該金属収斂剤の約25〜約95重量%の範囲にある、請求項1の方法。
- 有蹄動物における毛状疣贅(乳頭腫性肚皮膚炎)を治療および予防する方法、該方法は:
(a)アルミニウムおよび鉄の少なくとも1種を含むポリマーの金属濃縮物を薄めることによって、収斂剤溶液を調製する工程;および
(b)毛状疣贅を治療および予防するために、動物の脚下部および蹄領域に該収斂剤溶液を適用する工程、
を含んでなる。 - 該ポリマーの金属濃縮物が、ポリ塩化アルミニウム、ポリ硫酸アルミニウム、ポリアルミニウムクロロ硫酸塩、ポリアルミニウムシリケートサルフェート、ポリ塩化第二鉄、ポリ硫酸第二鉄、およびポリアルミノ硫酸第二鉄の少なくとも1種を含む、請求項7の方法。
- 該収斂剤溶液中において金属含有量が、約0.01〜約1.5重量%の濃度である、請求項7の方法。
- 該収斂剤溶液が、ポリマー種とモノマー種との混合物を含み、そして該ポリマー種が、該収斂剤溶液の約25〜約95重量%である、請求項7の方法。
- 該収斂剤溶液を調製する工程が、増粘剤、界面活性剤、スキンコンディショナー、緩衝剤、フィルム形成ポリマー、抗菌剤、着色剤、マンサク、タンニン、およびティーツリー油の少なくとも1種を含む第2の濃縮物を希釈する工程、および該収斂剤溶液を生成するために、該希薄されたポリマーの金属濃縮物と該希薄された第2の濃縮物とを混合する工程を含む、請求項7の方法。
- 鉄およびアルミニウムの少なくとも1種を含む金属収斂剤、
ここで、該金属収斂剤は、ポリマー種とモノマー種との混合物であり、そして該ポリ
マー種は、該水溶液中において該金属収斂剤の約25〜約95重量%である;および、
界面活性剤および増粘剤の少なくとも1種、
を含んで成る、水溶液。 - 該水溶液が、約4.0〜6.0のpHを有する、請求項12の水溶液。
- 該界面活性剤が、抗菌界面活性剤、カチオン性界面活性剤、非イオン性界面活性剤、両性イオンの界面活性剤の少なくとも1種、および少なくとも1種のカチオン性界面活性剤と少なくとも1種のアニオン性界面活性剤との組み合わせを含む、請求項12の水溶液。
- 該増粘剤が、ヒドロキシエチルセルロース、キサンタンガム、カルボキシメチルセルロース、界面活性剤で増粘された系、会合した増粘剤、クレイおよびシリカの少なくとも1種を含む、請求項12の水溶液。
- 該水溶液が、スキンコンディショナー、緩衝剤、フィルム形成ポリマー、抗菌剤、着色剤、マンサク、タンニンおよびティーツリー油の少なくとも1種をさらに含む、請求項12の水溶液。
- 有蹄動物における毛状疣贅(乳頭腫性肚皮膚炎)を治療および予防する方法、該方法は:
(a)鉄およびアルミニウムの少なくとも1種を含み、そして毛状疣贅病の治療および予防に治療的に有効である水溶液中濃度を有する金属収斂剤を含む水溶液を調製する工程;および
(b)動物の脚下部および蹄領域への泡としての該水溶液を適用する工程、
該泡は、0.05〜0.5g/mLの範囲の密度を有する、
を含んで成る。 - 該水溶液が、該動物の該脚下部および蹄領域に適用された場合に、該水溶液の表面張力を低下させる界面活性剤を含み、そして該水溶液中の該界面活性剤の濃度が、約0.05〜約1.0重量%である、請求項17の方法。
- 該水溶液が、該動物の該脚下部および蹄領域上において該水溶液の保持を促進するように構成され、そして約14〜100センチポイズの粘度を有する増粘剤を含む、請求項17の方法。
- 該動物の該脚下部および蹄領域に泡として該水溶液を適用する工程が、溝に該泡を投与する工程;および該溝を通るように該動物を移動させる工程を含む、請求項17の方法。
- 該動物の該脚下部および蹄領域に泡として該水溶液を適用する工程が、該水溶液の投与のために自動化された機器を含む、請求項17の方法。
- 有蹄動物における毛状疣贅(乳頭腫性肚皮膚炎)を治療および予防する方法、該方法は:
(a)鉄およびアルミニウムの少なくとも1種を含む金属収斂剤を含み、そして毛状疣贅病を治療および予防するのに治療的に有効である水溶液中濃度を有する水溶液を調製する工程;および
(b)動物の脚下部および蹄領域上に該水溶液をスプレーする工程、
該水溶液の粘度は、20センチポイズ以上である、
を含んで成る。 - 該動物の該脚下部および蹄領域上に該水溶液をスプレーする工程が、該水溶液の投与のための自動化された機器を含む、請求項22の方法。
- 該水溶液が、ヒドロキシエチルセルロース、キサンタンガム、カルボキシメチルセルロース、界面活性剤で増粘された系、会合した増粘剤、シリカおよびそれらの組み合わせから成る群から選択された増粘剤を含む、請求項22の方法。
- 該水溶液が、カチオン性界面活性剤を有する界面活性剤の系とアニオン性対イオン界面活性剤とを混合することを含む、請求項22の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/977,613 US8703104B2 (en) | 2007-10-25 | 2007-10-25 | Use of metal astringents for the treatment of hairy heel warts |
US11/977,613 | 2007-10-25 | ||
PCT/IB2008/054388 WO2009053934A2 (en) | 2007-10-25 | 2008-10-23 | Use of metal astringents for the treatment and prevention of hairy heel warts |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011500790A true JP2011500790A (ja) | 2011-01-06 |
JP2011500790A5 JP2011500790A5 (ja) | 2011-12-08 |
JP5643098B2 JP5643098B2 (ja) | 2014-12-17 |
Family
ID=40580177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010530613A Active JP5643098B2 (ja) | 2007-10-25 | 2008-10-23 | 毛状疣贅の治療および予防のための金属収斂剤の使用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8703104B2 (ja) |
EP (1) | EP2207557B1 (ja) |
JP (1) | JP5643098B2 (ja) |
CN (1) | CN101854940B (ja) |
CA (1) | CA2700711C (ja) |
NZ (1) | NZ584054A (ja) |
WO (1) | WO2009053934A2 (ja) |
ZA (1) | ZA201002068B (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013125440A1 (ja) * | 2012-02-23 | 2013-08-29 | 株式会社大阪製薬 | 動物向け外皮用製剤 |
JP2014534323A (ja) * | 2011-11-11 | 2014-12-18 | ザ プロクター アンド ギャンブルカンパニー | シールド塩類を含有する表面処理組成物 |
WO2015002264A1 (ja) | 2013-07-03 | 2015-01-08 | 三菱化学フーズ株式会社 | 毛状疣贅病の予防および/または治療方法 |
JP2018518495A (ja) * | 2015-06-23 | 2018-07-12 | エコラボ ユーエスエー インコーポレイティド | 噴霧塗布による乳頭治療用の水性抗菌膜形成性組成物 |
JP2020122020A (ja) * | 2015-06-23 | 2020-08-13 | エコラボ ユーエスエー インコーポレイティド | 噴霧塗布による乳頭治療用の水性抗菌膜形成性組成物 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8840931B2 (en) * | 2008-08-22 | 2014-09-23 | Kuok Leong Tam | Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues |
DK2349231T3 (en) * | 2008-11-28 | 2017-12-04 | Agrochem Inc | COMPOSITIONS AND METHODS OF TREATMENT OF HEAD DISEASES |
EP2523670B1 (en) * | 2010-01-15 | 2018-04-11 | Ecolab INC. | Method for producing reservoir layer for hoof treatment and reservoir layer |
US11559053B1 (en) | 2016-09-23 | 2023-01-24 | Specialty Sales, LLC | Livestock footbath solutions and methods of use |
CN110225746A (zh) | 2016-11-09 | 2019-09-10 | 普罗维塔欧洲技术有限公司 | 用于治疗兽蹄感染的抗微生物制剂 |
CN107837398A (zh) * | 2017-09-25 | 2018-03-27 | 上海康臣生物科技有限公司 | 一种复合型奶牛蹄浴液及其制备方法 |
US10779525B2 (en) | 2018-01-16 | 2020-09-22 | Zin Research LLC | Treatment compound and method of application for hoof or foot disease in animals |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005296772A (ja) * | 2004-04-09 | 2005-10-27 | Tomooka Kaken Kk | 消化汚泥処理用凝集剤 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2824042A (en) * | 1954-06-18 | 1958-02-18 | Walter G Gibbons | Composition for preparation of burow's solution |
US3061512A (en) * | 1959-06-25 | 1962-10-30 | Borden Co | Dermatological preparation |
US3265571A (en) * | 1965-04-08 | 1966-08-09 | Barnes Hind Pharm Inc | Thixotropic acne vulgaris composition |
US3856941A (en) * | 1972-05-23 | 1974-12-24 | Sobel J | Astringent gel, its preparation and use |
US4537767A (en) * | 1973-01-29 | 1985-08-27 | Pharmacia Aktiebolag | Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method |
US4073887A (en) * | 1973-02-09 | 1978-02-14 | Edward Price McLean, Sr. | Composition for treating ingrown toenails |
US4034750A (en) * | 1975-04-22 | 1977-07-12 | Maurice Seiderman | Electrochemically linking collagen fibrils to animal tissue |
US4268504A (en) * | 1977-10-12 | 1981-05-19 | Harrington John G | Composition and method for the treatment of animal hooves |
US4362643A (en) * | 1979-07-06 | 1982-12-07 | Allied Corporation | Aqueous basic polyaluminum-iron halide solutions |
US4284611A (en) * | 1979-07-25 | 1981-08-18 | Allied Chemical Corporation | Aqueous phosphate-stabilized polyaluminum sulfate solutions and preparation thereof |
US4388308A (en) * | 1980-06-09 | 1983-06-14 | G.D. Searle & Co. | N6 -[(2-Hydroxypropyl)aryl]adenosines |
US4551100A (en) * | 1982-06-07 | 1985-11-05 | Ultradent, Inc. | Method of preparing gingival area for dental crowns |
SE439006B (sv) * | 1982-11-02 | 1985-05-28 | Boliden Ab | Forfarande for framstellning av sulfatfattiga, flerkerniga aluminiumhydroxidsulfatkomplex |
US4895517A (en) * | 1987-04-14 | 1990-01-23 | Ultradent Products, Inc. | Methods for performing vital dental pulpotomy |
US4945084A (en) * | 1987-07-08 | 1990-07-31 | Norman Oksman | Method and composition for topically treating anorectal or other dermal wounds |
US5246686A (en) * | 1988-01-29 | 1993-09-21 | Atochem | Basic aluminum chlorosulfate flocculating agents |
US4879116A (en) * | 1988-06-13 | 1989-11-07 | Charles Fox | Skin protein complexing composition for the potentiation of the substantivity of aluminum acetate through the use of a cationic emulsifier as an aid in skin healing |
US4840798A (en) * | 1988-07-27 | 1989-06-20 | Theon, Inc. | Astringent gel composition and method for use |
SE8900478L (sv) * | 1989-02-13 | 1990-08-14 | Boliden Kemi Ab | Foerfarande foer framstaellning av polyaluminiumfoereningar |
US6451341B1 (en) * | 1990-02-05 | 2002-09-17 | Thomas J. Slaga | Time release formulation of vitamins, minerals and other beneficial supplements |
GB2250196B (en) | 1990-11-20 | 1994-05-25 | John Napier Beatson Irving | Method of hardening a hoof and waterproofing composition |
US5250569A (en) * | 1991-04-22 | 1993-10-05 | Godfrey Science & Design, Inc. | Amino acid flavorings of aluminum astringent for oral use |
US5575995A (en) * | 1991-08-15 | 1996-11-19 | Giovanoni; Richard L. | Ferric subsulfate gel and methods of using same |
FR2687394B1 (fr) * | 1992-02-18 | 1994-03-25 | Elf Atochem Sa | Nouveaux polychlorosulfates d'aluminium, procede pour leur preparation et leurs applications. |
DE69425142T2 (de) * | 1993-06-01 | 2001-03-22 | Ecolab Inc | Verdickte reiniger fuer harte oberflaechen |
US5653994A (en) * | 1993-10-25 | 1997-08-05 | Schneider; Norman S. | Composition and methods for treating burns and other trauma of the skin |
US5534245A (en) * | 1994-02-22 | 1996-07-09 | Helene Curtis, Inc. | Antiperspirant deodorant compositions |
GB9404191D0 (en) * | 1994-03-04 | 1994-04-20 | Imperial College | Preparations and uses of polyferric sulphate |
US5772985A (en) * | 1995-09-08 | 1998-06-30 | Alcide Corporation | Method for treating bovine hairy heel warts |
CN1196711A (zh) * | 1995-09-18 | 1998-10-21 | 德尔塔化学有限公司 | 聚氯化铝和聚氯硫酸铝的制备方法及组合物 |
US5630379A (en) * | 1996-02-12 | 1997-05-20 | Ssi Corporation | Electrically controlled spraying device for cleaning and treating animals |
BR9706543A (pt) * | 1996-08-01 | 1999-12-28 | Dale Wallis | Serpens spp biologicamente pura cepa hbl-112, composição farmacêutica e processos para evitar e/ou tratar dermatite digital papilomatosa de ruminante, e para determinar a presença de anticorpos pdd em uma amostra de soro e de anticorpos anti-serpens spp. em um ruminante, e, kit de diagnóstico |
US5916447A (en) * | 1996-10-15 | 1999-06-29 | Eka Chemicals Ab | Method for water treatment |
US6028104A (en) * | 1997-01-30 | 2000-02-22 | Ecolab Inc. | Use of peroxygen compounds in the control of hairy wart disease |
US5780064A (en) * | 1997-09-12 | 1998-07-14 | Babson Bros. Co. | Germicidal compositions for the treatment of animal infectious diseases of the hoof |
NL1008795C2 (nl) * | 1998-04-02 | 1999-10-05 | Rene Werenfridus Lodewijk Vroo | Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling. |
US6168794B1 (en) * | 1998-11-03 | 2001-01-02 | Safe 'n Sound Solutions, Inc. | Compositions comprising oleum Melaleuca |
FR2785768B1 (fr) * | 1998-11-17 | 2001-02-23 | Henkel Ecolab Snc | Procede de traitement des pieds des mammiferes et en particulier des bovins |
US6436445B1 (en) | 1999-03-26 | 2002-08-20 | Ecolab Inc. | Antimicrobial and antiviral compositions containing an oxidizing species |
US6479058B1 (en) * | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
US6656928B1 (en) * | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
US6444707B1 (en) * | 2000-08-22 | 2002-09-03 | West Agro | Topically applied hoof treatment composition and concentrate |
GB0022337D0 (en) * | 2000-09-12 | 2000-10-25 | Barrier Biotech Ltd | An antimicrobial composition |
DE10058363A1 (de) * | 2000-11-24 | 2002-06-06 | Henkel Ecolab Gmbh & Co Ohg | Verhinderung von Hufinfektionen in der Viehzucht |
US6482446B2 (en) * | 2000-12-01 | 2002-11-19 | Neutrogena Corporation | Astringent composition and method of use |
NL1017252C2 (nl) | 2001-01-31 | 2002-08-01 | A K B Beheermij B V | Waterige samenstelling voor toepassing bij dieren. |
US6652840B1 (en) * | 2001-02-21 | 2003-11-25 | Terence Prevendar | Bleeding control and healing aid compositions and methods of use |
US6568398B2 (en) | 2001-03-07 | 2003-05-27 | Edgar C. Cohen | Method for hemostasis |
WO2003103691A1 (en) * | 2001-06-07 | 2003-12-18 | Chiou Consulting, Inc. | Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
ATE337777T1 (de) * | 2001-06-15 | 2006-09-15 | Innovent Technology Ltd | Zusammensetzung zur behandlung von huf- und klauenerkrankungen |
US6803056B2 (en) * | 2001-09-14 | 2004-10-12 | Terence M. Dolak | Method and composition for treating viral outbreaks |
US20030190355A1 (en) * | 2002-04-05 | 2003-10-09 | Hermelin Marc S. | Modified release minerals |
US7163674B2 (en) * | 2002-05-09 | 2007-01-16 | The Procter & Gamble Company | Personal care compositions comprising a dicarboxy functionalized polyorganosiloxane |
US6530343B1 (en) * | 2002-06-13 | 2003-03-11 | General Chemical Corporation | Control of ammonia and phosphorus in milking parlors |
US6863898B2 (en) * | 2002-11-14 | 2005-03-08 | Michael D. Clawson | Method and composition for treating hairy hoof warts |
US7097861B1 (en) * | 2003-02-07 | 2006-08-29 | Jones-Hamilton Co. | Method of treating livestock footbath solutions |
US20050053672A1 (en) * | 2003-09-08 | 2005-03-10 | West Michael Howard | Synergistic metal salt-cationic surfactant-organic biocide composition |
US7258875B2 (en) * | 2003-12-04 | 2007-08-21 | Chiou Consulting, Inc. | Compositions and methods for topical treatment of skin infection |
-
2007
- 2007-10-25 US US11/977,613 patent/US8703104B2/en active Active
-
2008
- 2008-10-23 CN CN2008801130132A patent/CN101854940B/zh active Active
- 2008-10-23 JP JP2010530613A patent/JP5643098B2/ja active Active
- 2008-10-23 EP EP08841224.2A patent/EP2207557B1/en active Active
- 2008-10-23 CA CA2700711A patent/CA2700711C/en active Active
- 2008-10-23 WO PCT/IB2008/054388 patent/WO2009053934A2/en active Application Filing
- 2008-10-23 NZ NZ584054A patent/NZ584054A/en unknown
-
2010
- 2010-03-24 ZA ZA2010/02068A patent/ZA201002068B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005296772A (ja) * | 2004-04-09 | 2005-10-27 | Tomooka Kaken Kk | 消化汚泥処理用凝集剤 |
Non-Patent Citations (5)
Title |
---|
JPN6013022994; 日本獣医師会雑誌 59巻1号, 2006, p.35-39 * |
JPN6013022997; 薬学雑誌 124, 11, 2004, p.833-840 * |
JPN6013022999; Colloids and Surfaces A: Physicochemical and Engineering Aspects 260, 1-3, 2005, p.109-117 * |
JPN6014021835; Proceedings of the 13th International Symposium and 5th Conference on Lameness in Ruminants , 2004, pp.150-151の要約 * |
JPN6014021838; Ziekte van Mortellaro of dermatitis digitalis bij melkvee , 2006, Katholieke Hogeschool KFMPFN * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014534323A (ja) * | 2011-11-11 | 2014-12-18 | ザ プロクター アンド ギャンブルカンパニー | シールド塩類を含有する表面処理組成物 |
WO2013125440A1 (ja) * | 2012-02-23 | 2013-08-29 | 株式会社大阪製薬 | 動物向け外皮用製剤 |
JPWO2013125440A1 (ja) * | 2012-02-23 | 2015-07-30 | 株式会社大阪製薬 | 動物向け外皮用製剤 |
WO2015002264A1 (ja) | 2013-07-03 | 2015-01-08 | 三菱化学フーズ株式会社 | 毛状疣贅病の予防および/または治療方法 |
JP5740062B1 (ja) * | 2013-07-03 | 2015-06-24 | 三菱化学フーズ株式会社 | 毛状疣贅病の予防および/または治療方法 |
US9603827B2 (en) | 2013-07-03 | 2017-03-28 | Mitsubishi-Kagaku Foods Corporation | Method for preventing and/or treating hairy wart disease |
JP2018518495A (ja) * | 2015-06-23 | 2018-07-12 | エコラボ ユーエスエー インコーポレイティド | 噴霧塗布による乳頭治療用の水性抗菌膜形成性組成物 |
JP2020122020A (ja) * | 2015-06-23 | 2020-08-13 | エコラボ ユーエスエー インコーポレイティド | 噴霧塗布による乳頭治療用の水性抗菌膜形成性組成物 |
US11116215B2 (en) | 2015-06-23 | 2021-09-14 | Ecolab Usa Inc. | Aqueous antimicrobial film-forming composition for teat treatment by spray application |
Also Published As
Publication number | Publication date |
---|---|
EP2207557A4 (en) | 2012-01-18 |
JP5643098B2 (ja) | 2014-12-17 |
US20090110645A1 (en) | 2009-04-30 |
EP2207557A2 (en) | 2010-07-21 |
WO2009053934A3 (en) | 2009-10-15 |
CA2700711A1 (en) | 2009-04-30 |
CN101854940B (zh) | 2013-01-23 |
CA2700711C (en) | 2016-05-17 |
EP2207557B1 (en) | 2018-05-30 |
CN101854940A (zh) | 2010-10-06 |
ZA201002068B (en) | 2010-12-29 |
WO2009053934A2 (en) | 2009-04-30 |
US8703104B2 (en) | 2014-04-22 |
NZ584054A (en) | 2011-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5643098B2 (ja) | 毛状疣贅の治療および予防のための金属収斂剤の使用 | |
US5772985A (en) | Method for treating bovine hairy heel warts | |
US5569461A (en) | Topical antimicrobial composition and method | |
CN104884044B (zh) | 含羧酸混合物的杀菌组合物以及作为局部消毒剂的应用 | |
EP2061454A1 (en) | Compositions comprising a c2-c14 carboxylic acid and a surfactant for treating hoof diseases | |
JP2012510469A (ja) | 蹄病を治療するための組成物及び方法 | |
US20090110751A1 (en) | Compositions and Methods for Treatment of Diseases of the Foot of an Animal | |
WO2000028817A1 (en) | Teat disinfectant | |
NL2009707C2 (en) | Treatment and prevention of epithelial infections. | |
JP2003512332A (ja) | 乳腺炎の制御のためのヨウ素含有抗微生物組成物 | |
CN107410317A (zh) | 提高在湿巾面料中的扩散性的湿巾组合物及含有该组合物的湿巾 | |
US20030206882A1 (en) | Fatty acid sanitizer | |
WO2015103387A1 (en) | Dairy farm teat dip compositions and methods | |
EP2523670B1 (en) | Method for producing reservoir layer for hoof treatment and reservoir layer | |
US6852340B1 (en) | Biocide composition containing propionic acid and iodine compounds | |
US20150306062A1 (en) | Treatment and prevention of epithelial infections | |
CN113163754B (zh) | 稳定的含碘抗微生物乳头浸液组合物 | |
AU2013101672A4 (en) | A formulation for topical administration and a method of its use | |
CA3207295A1 (en) | Formulation comprising chlorite and percarbonate salts | |
WO2014070210A2 (en) | Antimicrobial hoof bath compositions and methods of using same | |
NZ605317A (en) | A Formulation for Topical Administration And A Method Of Its Use | |
NZ605317B (en) | A Formulation for Topical Administration And A Method Of Its Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111021 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111021 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130521 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130820 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130827 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130913 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140603 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140829 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140930 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141030 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5643098 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |